1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Bulgaria Pharmaceuticals and Healthcare Report Q3 2015

Bulgaria Pharmaceuticals and Healthcare Report Q3 2015

  • May 2015
  • -
  • Business Monitor International
  • -
  • 105 pages

Includes 3 FREE quarterly updates

BMI View: Pharmaceutical manufacturers will face increased pricing pressures from the National Health Insurance Fund (NHIF) as we expect a wave of cost-containment measures to be adopted. The NHIF will leverage its purchasing power to reduce its runaway pharmaceutical expenditure, with negative implications for the sector's growth profile. We expect generic drug penetration to rise and patented drug sales to slow considerably as the NHIF rebalances its expenditures.

Headline Expenditure Projections
- Pharmaceuticals: BGN2.53bn (USD1.72bn) in 2014 to BGN2.46bn (USD1.38bn) in 2015; -2.7% in local currency terms and -19.5% in US dollar terms. Forecast revised downwards from Q115.
- Healthcare: BGN6.04bn (USD4.10bn) in 2014 to BGN5.97bn (USD3.35bn) in 2015; -1.2% in local currency terms and -18.3% in US dollar terms. Forecast revised significantly downwards from Q115.

Table Of Contents

Bulgaria Pharmaceuticals and Healthcare Report Q3 2015
BMI Industry View 7
SWOT 9
Political . 11
Economic .. 12
Operational Risk . 13
Industry Forecast .. 15
Pharmaceutical Market Forecast . 15
Table: Pharmaceutical Sales, Historical Data And Forecasts (Bulgaria 2011-2019) . 16
Healthcare Market Forecast . 17
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Bulgaria 2011-2019) 19
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Bulgaria 2011-2019) . 19
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Bulgaria 2011-2019) 19
Prescription Drug Market Forecast 20
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Bulgaria 2011-2019) . 21
Patented Drug Market Forecast .. 22
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Bulgaria 2011-2019) 24
Generic Drug Market Forecast 25
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Bulgaria 2011-2019) . 26
OTC Medicine Market Forecast .. 27
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Bulgaria 2011-2019) 28
Pharmaceutical Trade Forecast .. 29
Table: Pharmaceutical Trade Data And Forecasts (Bulgaria 2013-2019) 30
Table: Pharmaceutical Trade Data And Forecasts local currency (Bulgaria 2013-2019) 31
Key Risks To BMI's Forecast Scenario .. 32
Macroeconomic Forecasts .. 33
Economic Analysis .. 33
Table: GDP Contribution To Growth (Bulgaria 2012-2020) 39
Industry Risk Reward Ratings 40
Central And Eastern Europe Risk/Reward Index .. 40
Bulgaria Risk/Reward Index . 46
Rewards .. 46
Risks . 47
Market Overview 48
Industry Trends And Developments .. 50
Epidemiology . 50
Table: Cancer Incidence Rates, 2012-2035 52
Healthcare Sector . 53
Table: Healthcare Resources (Bulgaria 2009-2014) . 54
Table: Healthcare Personnel (Bulgaria 2009-2014) . 54
Table: Healthcare Activity (Bulgaria 2009-2014) 55
Healthcare Insurance 55
Healthcare Reform Through To 2020 56
Reforming The Health Insurance Model .. 57
Healthcare Financing .. 58
Table: NHIF Budget, 2014 59
Table: Bulgarian National Health Insurance Fund Revenues (BGN 000s), 2015 . 59
Research and Development 60
Table: Members Of ARPharM, 2014 . 60
Clinical Trials 61
Regulatory Development .. 62
Pharmaceutical Advertising 63
Intellectual Property Environment . 64
Pricing Regime .. 65
Recent Pricing Developments . 67
Drug Policy Amendments 67
Reimbursement Regime 68
Reimbursement Regime Developments . 70
Competitive Landscape . 71
Research-Based Industry . 71
Generic Drugmakers 71
Pharmaceutical Retail Sector . 72
Wholesale Sector .. 73
Table: Pharmaceutical Wholesale And Retail Market, 2009-2012 . 74
Company Profile . 75
Sopharma . 75
Biovet . 79
Actavis Bulgaria .. 81
GlaxoSmithKline . 84
Novartis . 86
Sanofi . 88
Pfizer . 90
Merck and Co .. 92
Demographic Forecast .. 94
Demographic Outlook 94
Table: Population Headline Indicators (Bulgaria 1990-2025) . 95
Table: Key Population Ratios (Bulgaria 1990-2025) 95
Table: Urban/Rural Population and Life Expectancy (Bulgaria 1990-2025) 96
Table: Population By Age Group (Bulgaria 1990-2025) . 96
Table: Population By Age Group % (Bulgaria 1990-2025) 97
Glossary .. 99
Methodology .. 101
Pharmaceutical Expenditure Forecast Model .. 101
Healthcare Expenditure Forecast Model 101
Notes On Methodology .. 102
Risk/Reward Index Methodology . 103
Index Overview 104
Table: Pharmaceutical Risk/Reward Index Indicators 104
Indicator Weightings . 105

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Drug Discovery Outsourcing Global Market  – Forecast To 2022

Drug Discovery Outsourcing Global Market – Forecast To 2022

  • $ 15 000
  • Industry report
  • January 2016
  • by IQ4I Research & Consultancy Pvt. Ltd

Over the last two decades, the Pharmaceutical/Biotech industry has undergone radical changes. The unprecedented downsizing of the internal discovery of big pharmaceuticals, patent expiration, shift towards ...

Global Markets for Infectious Disease Treatments

Global Markets for Infectious Disease Treatments

  • $ 6 650
  • Industry report
  • January 2016
  • by BCC Research

This BCC Research report provides the reader with a detailed analysis of the global infectious disease market, with emphasis on seven major infectious diseases (i.e., human immunodeficiency virus/acquired ...

Pancreatic Cancer Therapeutics in Major Developed Markets to 2021 - Strong Late Stage Pipeline Holds Promise for Increasingly Diverse Market Landscape

Pancreatic Cancer Therapeutics in Major Developed Markets to 2021 - Strong Late Stage Pipeline Holds Promise for Increasingly Diverse Market Landscape

  • $ 4 995
  • Industry report
  • December 2015
  • by GBI Research

Pancreatic Cancer Therapeutics in Major Developed Markets to 2021 - Strong Late Stage Pipeline Holds Promise for Increasingly Diverse Market Landscape Summary Pancreatic Cancer (PC) is a disease predominately ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.